These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 30199912)

  • 1. [Individualized Treatment of Chronic Lymphocytic Leukemia (CLL)].
    von Tresckow J; Hallek M; Eichhorst B
    Dtsch Med Wochenschr; 2018 Sep; 143(18):1318-1324. PubMed ID: 30199912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic markers and standard management of chronic lymphocytic leukemia.
    Stilgenbauer S
    Hematology Am Soc Hematol Educ Program; 2015; 2015():368-77. PubMed ID: 26637745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frontline Treatment for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): Targeted Therapy vs. Chemoimmunotherapy.
    Small S; Ma S
    Curr Hematol Malig Rep; 2021 Aug; 16(4):325-335. PubMed ID: 34021874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic lymphocytic leukemia international prognostic index (CLL-IPI) in patients receiving chemoimmuno or targeted therapy: a systematic review and meta-analysis.
    Molica S; Giannarelli D; Mirabelli R; Levato L; Shanafelt TD
    Ann Hematol; 2018 Oct; 97(10):2005-2008. PubMed ID: 29740683
    [No Abstract]   [Full Text] [Related]  

  • 5. [Chronic lymphocytic leukemia : treatment concepts in transition].
    Eichhorst B; Hallek M
    Internist (Berl); 2015 Apr; 56(4):374-80. PubMed ID: 25776793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early intervention in asymptomatic chronic lymphocytic leukemia.
    Muchtar E; Kay NE; Parikh SA
    Clin Adv Hematol Oncol; 2021 Feb; 19(2):92-103. PubMed ID: 33596191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bruton tyrosine kinase inhibition in chronic lymphocytic leukemia.
    Maddocks K; Jones JA
    Semin Oncol; 2016 Apr; 43(2):251-9. PubMed ID: 27040703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of prognostic factors in assessing 'high-risk' subgroups of patients with chronic lymphocytic leukemia.
    Kay NE; O'Brien SM; Pettitt AR; Stilgenbauer S
    Leukemia; 2007 Sep; 21(9):1885-91. PubMed ID: 17568813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic Lymphocytic Leukemia: Current Concepts.
    Yu EM; Kittai A; Tabbara IA
    Anticancer Res; 2015 Oct; 35(10):5149-65. PubMed ID: 26408673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An international prognostic index for patients with chronic lymphocytic leukaemia (CLL-IPI): a meta-analysis of individual patient data.
    International CLL-IPI working group
    Lancet Oncol; 2016 Jun; 17(6):779-790. PubMed ID: 27185642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chronic lymphocytic leukaemia: current management].
    Aurran-Schleinitz T; Arnoulet C; Ivanov V; Coso D; Rey J; Schiano JM; Stoppa AM; Bouabdallah R; Gastaut JA
    Rev Med Interne; 2008 May; 29(5):424-35. PubMed ID: 18359538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of unfit elderly patients with chronic lymphocytic leukemia.
    Eichhorst B; Hallek M; Goede V
    Eur J Intern Med; 2018 Dec; 58():7-13. PubMed ID: 30527922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic lymphocytic leukemia therapy: beyond chemoimmunotherapy.
    Delgado J; Baumann T; Ghita G; Montserrat E
    Curr Pharm Des; 2012; 18(23):3356-62. PubMed ID: 22591384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment approach for elderly and unfit patients with chronic lymphocytic leukemia.
    Innocenti I; Autore F; Pasquale R; Morelli F; Efremov DG; Laurenti L
    Expert Rev Hematol; 2017 Dec; 10(12):1069-1076. PubMed ID: 29082795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic Lymphocytic Leukemia in the Elderly, Which Investigations Are Necessary: A Map for the Practicing Oncologist.
    Pinilla-Ibarz J; Emole J
    Cancer Control; 2015 Oct; 22(4 Suppl):7-16. PubMed ID: 26618341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chronic lymphocytic leukemia: pathophysiology and current therapy].
    Takizawa J
    Rinsho Ketsueki; 2017; 58(5):471-479. PubMed ID: 28592762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Idelalisib for the treatment of chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Barrientos JC
    Future Oncol; 2016 Sep; 12(18):2077-94. PubMed ID: 27324214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CLL update 2022: A continuing evolution in care.
    Kay NE; Hampel PJ; Van Dyke DL; Parikh SA
    Blood Rev; 2022 Jul; 54():100930. PubMed ID: 35151528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic markers in patients with chronic lymphocytic leukaemia on targeted therapy, chemoimmunotherapy with anti-CD20 monoclonal antibody: a systematic review and meta-analysis of prognostic factors.
    Mkhwanazi ZA; Nyambuya TM; Mfusi SA; Nkambule BB
    BMC Cancer; 2022 Nov; 22(1):1218. PubMed ID: 36434612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of chronic lymphocytic leukaemia.
    Kalil N; Cheson BD
    Drugs Aging; 2000 Jan; 16(1):9-27. PubMed ID: 10733261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.